Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Powai, Mumbai, Maharashtra, India.
Phys Chem Chem Phys. 2022 Jul 13;24(27):16694-16700. doi: 10.1039/d1cp04454k.
Microtubules (MTs) are widely targeted for the treatment of various types of cancer due to their essential role in cell division. MTs are polymers made of -tubulin heterodimers. These - and -tubulins have 8 and 10 different isotypes, respectively. It is known that a few tubulin isotypes have anti-cancer drug resistance properties, especially , which shows poor sensitivity to many potent anti-cancer drugs such as eribulin. However, the molecular-level understanding of drug-resistance due to tubulin isotype variation is poorly understood. This paper presents the study of differential binding affinities of different tubulin isotypes with the potent anti-cancer drug eribulin. Eribulin (MT destabilizer) binds at the inter-dimer interface of MTs near the vinca site and induces a lattice deformation, which results in catastrophic events in MT dynamics. In this study, sequence analysis has been done throughway and the binding sites and based on that 2-tubulin isotypes ( and ) and 7 tubulin isotypes (, , , , , and ) were selected. In total, 14 combinations were prepared after building homology models of these selected isotypes. Molecular docking and molecular dynamics simulations were performed to deeply understand the binding mode of eribulin at different MT compositions. RMSD, RMSF, radius of gyration, SASA, ligand-protein interactions, and calculations of binding free energy were performed to investigate the eribulin binding variations to tubulin isotypes and it was found that showed the maximum binding affinity among all 14 systems to eribulin. The -tubulin isotype, which shows low sensitivity to eribulin in experimental results, had the least binding affinity in the system complex and the average binding affinity in the system among all 14 systems. Additionally, we performed steered MD simulations and DynDom analysis of the systems with the lowest binding energy () and the highest binding energy () and extracted force, displacement, and H-bonding profiles during the pulling simulations to get a better insight.
微管(MTs)由于在细胞分裂中的重要作用而被广泛用于治疗各种类型的癌症。MTs 是由 -tubulin 异二聚体组成的聚合物。这些 - 和 -tubulins 分别具有 8 种和 10 种不同的同种型。已知一些微管蛋白同种型具有抗癌药物耐药性,特别是 ,它对许多有效的抗癌药物如埃博霉素的敏感性较差。然而,由于微管蛋白同种型变化导致耐药性的分子水平理解还很不清楚。本文研究了不同微管蛋白同种型与有效抗癌药物埃博霉素的差异结合亲和力。埃博霉素(MT 解稳定剂)结合在 MT 近长春碱结合部位的二聚体界面上,并诱导晶格变形,从而导致 MT 动力学中的灾难性事件。在这项研究中,通过序列分析,并基于此选择了 2 种微管蛋白同种型(和 )和 7 种微管蛋白同种型(、、、、、和 )。总共制备了 14 种组合,这些选择的同种型的同源模型建立后。进行分子对接和分子动力学模拟,以深入了解埃博霉素在不同 MT 组成中的结合模式。进行 RMSD、RMSF、回转半径、SASA、配体-蛋白相互作用和结合自由能的计算,以研究埃博霉素与微管蛋白同种型的结合变化,并发现所有 14 种系统中 显示出对埃博霉素的最大结合亲和力。在实验结果中对埃博霉素敏感性较低的 -tubulin 同种型在系统 中具有最小的结合亲和力,在所有 14 种系统中在系统 中的平均结合亲和力最低。此外,我们对具有最低结合能()和最高结合能()的系统进行了导向 MD 模拟和 DynDom 分析,并在拉伸模拟过程中提取力、位移和氢键形成谱,以获得更好的洞察力。